10x Genomics 'overjoyed' to win UPC preliminary injunction

Decision marks first announcement by the UPC of an injunction in open court | Ruling in Munich Local Division forecast to have far-reaching consequences for defendant | Comment from 10x vice president of IP and litigation, Randy Wu.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

‘The EPO can manage it—I’m baffled why the UPC can’t’: Test case challenges court’s ‘request for access’ rule

28 November 2023 Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger.

Big Pharma

UPC confirms dates for 10x Genomics hearings

22 August 2023 UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.

Americas

Munich court rules for Bio-Rad in 10x Genomics dispute

3 December 2019 California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

10x Genomics 'overjoyed' to win UPC preliminary injunction

More on this story

Editor's picks

Editor's picks

More features